Ranibizumab for the treatment of wet AMD: a summary of real-world studies
Ranibizumab for the treatment of wet AMD: a summary of real-world studies
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Data from real-world studies of ranibizumab in neovascular (wet) age-related macular degeneration suggest that outcomes in clinical practice fail to match those seen in clinical trials. These real-world studies follow treatment regimens that differ from the fixed dosing used in the pivotal clinical trial programme. To better understand the effectiv...
Alternative Titles
Full title
Ranibizumab for the treatment of wet AMD: a summary of real-world studies
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4763117
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4763117
Other Identifiers
ISSN
0950-222X
E-ISSN
1476-5454
DOI
10.1038/eye.2015.217
